Antisecretory Factor in Primary Glioblastoma 1

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
GlioblastomaCerebral EdemaChemotherapy Effect
Interventions
DIETARY_SUPPLEMENT

Salovum

Egg yolk powder enriched for anti secretory factor

Trial Locations (1)

22185

Department of Neurosurgery, Lund

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Region Skane

OTHER

collaborator

Lund University

OTHER

collaborator

Skane University Hospital

OTHER

collaborator

Lantmannen Medical AB

OTHER

lead

Peter Siesjö

OTHER